An upward compatible modality over CAR-T · info@kohjin-bio.co.jp } +W$5 :b7% TkMm=;9D; x4 , x20 m,...

Preview:

Citation preview

Cat. No. 16030400

An upward compatible modality over CAR-T

ü Highly purified and near-fully activated

ü Unique phenotype

ü Simple and highly reproducible

ü Sufficient yield

ü Cost effective

< for RESEARCH USE ONLY >

l ~l 3 3 ( sl E:T=1:1 , 2 s m

NK-resistant Raji

l ce 2 ) - //1 0/ 7ce

:

TEL : 049-284-3781info@kohjin-bio.co.jp

:

info@gaia-biomed.com

< for RESEARCH USE ONLY >

x4

,

x20

m ,

x20

m

CD56

CD3

day0 day14

CD3, CD56, CD16 Marker Isotype control

CD16

NK: = 1:137℃ , 2 s

+ 3CD3, CD56, CD16 Isotype control

> : ,

AB 4 12181301 CD3 Dynabeads™ CD3, Invitrogen, 11151D Ficoll-Paque™ OptiPrep™ < PBMC

AdoptCellⓇ-NKNK

Cat. No. 16030400

Recommended